Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China flag China · Delayed Price · Currency is CNY
17.21
+0.36 (2.14%)
Feb 3, 2026, 1:35 PM CST

SHA:603858 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
885.59818.81694.132,1491,2181,470
Short-Term Investments
-----3.6
Trading Asset Securities
679.28403.75354.09726.45498.17386.45
Cash & Short-Term Investments
1,5651,2231,0482,8751,7161,860
Cash Growth
19.31%16.63%-63.54%67.56%-7.73%-16.07%
Accounts Receivable
1,4111,2581,8871,9052,1712,639
Other Receivables
90.38114.03152.16164.69200.57324.83
Receivables
1,5021,3722,0392,0702,3722,964
Inventory
4,5174,6244,9303,7893,8342,767
Other Current Assets
345.34317.76263.32257.42430.37395.99
Total Current Assets
7,9297,5378,2818,9918,3527,986
Property, Plant & Equipment
4,9285,6646,0006,3015,9195,343
Long-Term Investments
1,5541,5251,4961,4491,4331,437
Goodwill
620.04620.041,4732,0635,1335,122
Other Intangible Assets
850.45809.53949.171,0741,1711,241
Long-Term Accounts Receivable
---16.7523.3216.75
Long-Term Deferred Tax Assets
327.64389.32368.19221.38220.68170.57
Long-Term Deferred Charges
1,8011,6991,3861,125978.44870.21
Other Long-Term Assets
1,5601,085938.55710.55754.32699.33
Total Assets
19,57019,32920,89221,95223,98622,886
Accounts Payable
2,4692,8462,4972,3982,4951,938
Accrued Expenses
95.241,6372,2862,3181,9032,023
Short-Term Debt
343.56486.46240.12638.761,2952,561
Current Portion of Long-Term Debt
1,2441,123737.93307.04307.4268.9
Current Portion of Leases
-46.0464.3253.6914.96-
Current Income Taxes Payable
143.5137.375.695.54118.67136.94
Current Unearned Revenue
434.74215.76238376.52242.4335.7
Other Current Liabilities
2,193710.86717.29773.22786.25749.57
Total Current Liabilities
6,9227,1026,8566,9617,1627,813
Long-Term Debt
2,0471,9862,0982,1271,902824.32
Long-Term Leases
201.0174.62154.58170.3719.14-
Long-Term Unearned Revenue
253.66283.59312.29330.55345.63340.29
Long-Term Deferred Tax Liabilities
72.171.2490.5287.51106.2297.36
Other Long-Term Liabilities
2.713.025.07---
Total Liabilities
9,4989,5209,5169,6779,5369,075
Common Stock
1,0551,1061,1061,1061,1421,142
Additional Paid-In Capital
1,7322,4932,4932,4943,3923,385
Retained Earnings
7,7757,3188,0088,75110,80610,122
Treasury Stock
--712.38-1.85--934-934
Comprehensive Income & Other
11.1811.2311.8412.1319.30.5
Total Common Equity
10,57310,21611,61712,36314,42513,715
Minority Interest
-500.91-408.38-240.98-87.5825.1796.19
Shareholders' Equity
10,0729,80811,37612,27514,45013,811
Total Liabilities & Equity
19,57019,32920,89221,95223,98622,886
Total Debt
3,8353,7163,2953,2973,5393,455
Net Cash (Debt)
-2,270-2,493-2,247-421.83-1,823-1,595
Net Cash Per Share
-2.14-2.30-2.03-0.38-1.65-1.44
Filing Date Shares Outstanding
1,0551,0611,0951,1061,1061,106
Total Common Shares Outstanding
1,0551,0611,1061,1061,1061,106
Working Capital
1,0074351,4252,0301,190172.57
Book Value Per Share
10.039.6310.5011.1813.0412.40
Tangible Book Value
9,1028,7879,1959,2258,1217,351
Tangible Book Value Per Share
8.638.288.318.347.346.65
Buildings
-4,8915,0365,1953,2112,455
Machinery
-2,3302,0341,8251,5781,433
Construction In Progress
-1,1321,2431,2352,8212,918
Source: S&P Global Market Intelligence. Standard template. Financial Sources.